Scientific Literature Search

Source record

Advanced Parkinson's disease: clinical characteristics and treatment. Part II.

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia · 2013-07-21

DOI: 10.1016/j.nrl.2013.05.002PMID: 23880230

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.

Murray D, Stoessl AJ.

Pharmacol Ther · 2013-07-21

DOI: 10.1016/j.pharmthera.2013.07.009PMID: 23880289

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems.

Brichta L, Greengard P, Flajolet M.

Trends Neurosci · 2013-07-19

DOI: 10.1016/j.tins.2013.06.003PMID: 23876424

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.

Eisenhofer G, Brown S, Peitzsch M, Pelzel D, Lattke P, Glöckner S, Stell A, Prejbisz A, Fassnacht M, Beuschlein F, Januszewicz A, Siegert G, Reichmann H.

Ann Clin Biochem · 2013-07-19

DOI: 10.1177/0004563213487894PMID: 23873873

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The effect of Parkinson's disease and levodopa on adaptation of anticipatory postural adjustments.

Hall LM, Brauer SG, Horak F, Hodges PW.

Neuroscience · 2013-07-15

DOI: 10.1016/j.neuroscience.2013.07.006PMID: 23867768

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].

Neurologia · 2013-07-13

DOI: 10.1016/j.nrl.2013.05.001PMID: 23856182

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.

Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.

Mov Disord · 2013-07-12

DOI: 10.1002/mds.25561PMID: 23853029

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

Merola A, Rizzi L, Zibetti M, Artusi CA, Montanaro E, Angrisano S, Lanotte M, Rizzone MG, Lopiano L.

J Neurol Neurosurg Psychiatry · 2013-07-11

DOI: 10.1136/jnnp-2013-305271PMID: 23847290

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Rasagiline adjunct therapy in patients with Parkinson's disease: post hoc analyses of the PRESTO and LARGO trials.

Elmer LW.

Parkinsonism Relat Disord · 2013-07-10

DOI: 10.1016/j.parkreldis.2013.06.001PMID: 23849501

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Rasagiline treatment effects on parkinsonian tremor.

Lew MF.

Int J Neurosci · 2013-07-09

DOI: 10.3109/00207454.2013.812085PMID: 23767986

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Herrmann N, Lanctôt KL, Hogan DB.

Alzheimers Res Ther · 2013-07-08

DOI: 10.1186/alzrt201PMID: 24565367

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.

Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R, Picillo M, Merola A, Lopiano L, Paribello A, Manca D, Melis M, Marchese R, Borelli P, Mereu A, Contu P, Abbruzzese G, Bonuccelli U.

Mov Disord · 2013-07-08

DOI: 10.1002/mds.25585PMID: 23836370

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.728 articles found

Advanced Parkinson's disease: clinical characteristics and treatment. Part II.

Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.

Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems.

Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.

The effect of Parkinson's disease and levodopa on adaptation of anticipatory postural adjustments.

[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].

AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.

Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

Rasagiline adjunct therapy in patients with Parkinson's disease: post hoc analyses of the PRESTO and LARGO trials.

Rasagiline treatment effects on parkinsonian tremor.

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.

Filters